Friday 6 November 2026 Export ARGX’s income statement to Excel — free account

argenex SE

ARGX Healthcare Biotechnology

argenex SE’s revenue for fiscal 2025 (year ended December 2025) was $4.2 billion, up 88.6% from fiscal 2024.

Revenue: +52.1%
EPS: +43.9%
Free cash flow: +537.5%

Quarter to September 2026, against a year earlier

922.55 27.78 +3.10%

Follow ARGX

Alert me

Market cap: $56.3B
P/E: 29.8×
Fwd P/E: 30.1×
Dividend yield: —
F-score: 5/9
Altman Z: 24.36
Beneish M: −1.51
Dividend safety: n/a

Overview

argenex SE (ARGX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, argenex SE (ARGX) trades at a P/B ratio of 6.7×. Over the past ten years it has ranged from 0.0× (June 2019) to 10.7× (February 2021); the current reading is higher than 58% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ARGX/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="argenex SE P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ARGX/metrics/pb-ratio">argenex SE (ARGX) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	7.0×	5.14%
FY2024	6.7×	25.95%
FY2023	5.3×	(26.42%)
FY2022	7.2×	2.36%
FY2021	7.1×	(15.05%)
FY2020	8.3×	56.35%
FY2019	5.3×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/B ratio	Change
Sep 2026	7.1×	4.06%
Jun 2026	6.9×	10.99%
Mar 2026	6.2×	(12.08%)
Dec 2025	7.0×	(5.21%)
25 more quarters	Free account

Against its own ten years

Low 0.0× High 10.7×

Ten-year median 6.4×

Current reading's percentile 46

Company	P/B ratio
REGN Regeneron Pharmaceuticals, Inc. compare	2.7×
RPRX Royalty Pharma PLC compare	3.1×
INCY Incyte Corporation compare	4.3×
ROIV Roivant Sciences Ltd. compare	5.4×
GMAB Genmab A/S Sponsored ADR compare	5.5×
ARGX argenex SE	6.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	7.5×
MRNA Moderna, Inc. compare	14.2×
RVMD Revolution Medicines, Inc. compare	16.1×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

argenex SE (ARGX) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ARGX

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ARGX

Stockrow Weekly